Lead Vaccine Candidate for COVID-19

Johnson & Johnson announces an important finding in the fight against COVID-19!  As a result of its efforts in pharmaceutical research and innovation, this company announced that it will begin the phase of human clinical studies at the latest by September 2020.  This good news would mean an achievement in vaccine development, compared to the…

Coronavirus

Coronavirus, pharmaceutical research and global health

The Coronavirus outbreak (2019-nCoV) was  declared a pandemic by the Director-General of the World Health Organization (WHO), responding to the rapid spread of this pathology. This statement shows the dangerous nature of the virus, and the need to find effective treatments and strengthen available healthcare systems, especially in Latin America, which has already started reporting…

APEC Webinar: Opportunities for Latam

On January 21st, FIFARMA organized the Webinar entitled: APEC: Opportunities for Latam. This virtual talk discussed the opportunities in Latin America in regulatory training issues, especially in recent years. Our Executive Director Rafael Andrés Díaz-Granados moderated and opened this talk. APEC unveiled convergence and regulatory training opportunities for the region. The steering committee for harmonization…

IFPMA assumes its immunization role with two new reports

The International Federation of Manufacturers and Associations of Pharmaceutical Products (IFPMA) recently published two reports that contribute to research, development, implementation and dissemination of information on vaccines and immunization -essential topics in the improvement of global health. One of them is The complex journey of a vaccine, a report dealing with the process of developing…

ISPOR Latin America 2019

FIFARMA,  presente en las conversaciones regionales para la mejora permanente de políticas públicas de salud.  Esta vez en ISPOR Latin America 2019. ¿Cuándo? El 13 y 14 de septiembre 13 DE SEPTIEMBRE ¿De qué se hablará? Desde FIFARMA estaremos presentes en el pódium: Proposed Solutions to Achieving Healthcare Sustainability in Latin America. ¿A qué hora?…

FIFARMA and ALAFARPE presented results from the study “Analysis of access to innovative medicines in Peru compared to other OECD countries”

FIFARMA and ALAFARPE, presented the results of the study “Analysis of access to innovative medicines in Peru compared to OECD countries” on April 9th, within the framework of the Foro Innovación en Salud: Nuevas Tecnologías para el Bienestar de los Peruanos /Forum Innovation in Health: New Technologies for the Wellbeing of Peruvians.  The event was held at…

FIFARMA at CMC Strategy Forum Latin America 2019: The importance of harmonized guidelines and work sharing

The CMC Strategy Forum Latin America 2019 took place in Brazil, on March 12th-13th. The event focused on regulatory update and featured an opening session including presentations from regional regulators, as well as the FDA. FIFARMA was represented by Dr. Thomas Schreitmueller, Global Lead for Regulatory Policy at Roche and FIFARMA’s Regulatory & Biologics Working Group Co-Chair. Dr. Schreitmueller participated in…

FIFARMA at LARC 2019

The Drug Information Association (DIA) recently sponsored “Latin America Regulatory Conference 2019” in Miami, US on February 21st – 22nd. The symposium offered engaging panels led by health influencers discussing the advancement and implementation of regulatory convergence initiatives in Latin America. FIFARMA was represented in this event by Dr. Thomas Schreitmueller, Global Lead for Regulatory Policy at Roche and FIFARMA’s…

FIFARMA Local Associations Meeting 2019

FIFARMA’s annual local associations meeting was held on January 29th and 30th, 2019 in Santiago, Chile. Directors from all member associations had the opportunity to be involved in strategic discussions focused on improving and promoting healthcare for the Latin American population, and learning about the objectives of each Association in the region, which help guide…